INmune Bio

-$0.84 (-6.97%) Today

-$0.22 (-1.96%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.

About INMB

INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimer’s disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE.

CEO

Raymond J. Tesi

Employees

Headquarters

Boca Raton, Florida

Founded

2015

INMB Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

221.10K

High today

$12.13

Low today

$10.96

Open price

$11.95

Volume

226.28K

52 Week high

$30.37

52 Week low

$8.40

INMB News

Simply Wall StDec 2

Is INmune Bio Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it might be obvi

INMB Earnings

-$0.55

-$0.37

-$0.18

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected Mar 3, After Hours

Why Robinhood?

INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimer’s disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE. View more

Is INmune Bio Using Too Much Debt?

INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimer’s disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE.